From: Renal cancer: new models and approach for personalizing therapy
SIGNIFICANT PROTEINS Progr vs No Progr | p value |
---|---|
Vimentin | 0.004 |
HIF-1α | 0.005 |
4E-BP1 (T70) | 0.006 |
Cyclin D1 | 0.006 |
4E-BP1 (S65) | 0.009 |
4E-BP1 (T37/46) | 0.009 |
EGFR (Y1148) | 0.014 |
KRAS | 0.018 |
PKCθ (T538) | 0.023 |
IkBα (S32/36) | 0.027 |
mTOR (S2448) | 0.028 |
PLCγ1 (Y783) | 0.028 |
PKCα (S657) | 0.028 |
PKCζ/λ (T410/403) | 0.028 |
SGK1 (S78) | 0.028 |
Cox2 | 0.028 |
cKIT (Y703) | 0.039 |